umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis.
Umeå University, Faculty of Medicine, Surgical and Perioperative Sciences, Surgery.
2004 (English)In: Cancer Immunol Immunother, ISSN 0340-7004, Vol. 53, no 9, 840-1 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 53, no 9, 840-1 p.
Keyword [en]
Clinical Trials, Drug Therapy; Combination, Histamine/*therapeutic use, Immunotherapy, Interleukin-2/*therapeutic use, Liver Neoplasms/mortality/secondary/*therapy, Melanoma/mortality/pathology/*therapy, Survival Rate
Identifiers
URN: urn:nbn:se:umu:diva-16261PubMedID: 15127238OAI: oai:DiVA.org:umu-16261DiVA: diva2:155934
Available from: 2007-09-05 Created: 2007-09-05 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15127238&dopt=Citation

Search in DiVA

By author/editor
Naredi, Peter
By organisation
Surgery

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 136 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf